𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The ACCLAIM Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Immune Modulation Therapy in Patients with Heart Failure due to Systolic Left Ventricular Dysfunction

✍ Scribed by Guillermo Torre-Amione

Book ID
119214366
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
85 KB
Volume
12
Category
Article
ISSN
1532-8414

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale and design of a randomized, do
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study
✍ Kim Fox; Roberto Ferrari; Michal Tendera; Philippe Gabriel Steg; Ian Ford πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 193 KB
Rationale and design of a randomized con
Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failureβ€”the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study
✍ Cecilia Linde; Michael Gold; William T. Abraham; Jean-Claude Daubert πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 124 KB